# ğŸ§¬ AI-Driven Drug Discovery Pipeline for HIF-2Î± Modulators

[![License: MIT](https://img.shields.io/badge/License-MIT-yellow.svg)](https://opensource.org/licenses/MIT)
[![Python 3.8+](https://img.shields.io/badge/python-3.8+-blue.svg)](https://www.python.org/downloads/)
[![Contributions Welcome](https://img.shields.io/badge/contributions-welcome-brightgreen.svg?style=flat)](https://github.com/Socks2109/drug_discovery_pipeline/issues)

## ğŸ¯ Table of Contents

- [ğŸ¯ Objective](#-objective)
- [ğŸ“‹ Overview](#-overview)
- [ğŸ—ï¸ Project Structure](#ï¸-project-structure)
- [ğŸ”§ Installation & Setup](#-installation--setup)
- [ğŸš€ Quick Start](#-quick-start)
- [ğŸ“Š Pipeline Components](#-pipeline-components)
- [ğŸ“ˆ Results](#-results)
- [ğŸ”¬ DEMO](#-demo)
- [ğŸ“š Documentation](#-documentation)
- [ğŸ¤ Contributing](#-contributing)
- [ğŸ“„ License](#-license)
- [ğŸ™ Acknowledgments](#-acknowledgments)

## ğŸ¯ Objective

To design and implement an **AI-driven pipeline** for identifying novel small-molecule modulators targeting the **HIF-2Î± dimerization interface**, leveraging cutting-edge computational chemistry, machine learning, and large-scale screening technologies.

## ğŸ“‹ Overview

This project integrates artificial intelligence with computational drug discovery to prioritize and optimize candidates targeting biologically significant protein-protein interactions. Our modular pipeline demonstrates how emerging AI technologies, particularly Large Language Models (LLMs), can augment traditional docking-based drug discovery methods.

### ğŸ§ª Key Technologies
- **MolMIM**: Molecular generation using Mutual Information Machine
- **DiffDock**: AI-powered molecular docking
- **TxGemma**: Toxicity and pharmacokinetic prediction
- **SEA**: Similarity Ensemble Approach for library diversification
- **ZINC & TLDR**: Chemical compound databases

### ğŸ¯ Target
**HIF-2Î± (Hypoxia-Inducible Factor 2-alpha)** - A critical transcription factor involved in cellular oxygen sensing and cancer progression.

## ğŸ—ï¸ Project Structure

```
Drug_Discovery_Project/
â”œâ”€â”€ ğŸ“ 01 Library Generation/        # Compound library generation using MolMIM
â”‚   â”œâ”€â”€ SEA_MolMIM_SMILELibraryGeneration/
â”‚   â””â”€â”€ smiles/                      # SMILES validation and processing
â”‚
â”œâ”€â”€ ğŸ“ 02 Docking Pipeline/          # Molecular docking with DiffDock
â”‚   â”œâ”€â”€ AutoDOCK Pipeline/           # Alternative docking methods
â”‚   â””â”€â”€ results/                     # Docking results and analysis
â”‚
â”œâ”€â”€ ğŸ“ 03 TxGemma Pipeline/          # Toxicity & PK property prediction
â”‚   â”œâ”€â”€ Agentic_TxGemma_Toxicity.ipynb
â”‚   â””â”€â”€ Agentic_TxGemma_PK_Prop.ipynb
â”‚
â”œâ”€â”€ ğŸ“ 04 Final Workflow/            # Integrated pipeline execution
â”‚
â”œâ”€â”€ ğŸ“ DEMO/                         # Complete demonstration workflow
â”‚   â”œâ”€â”€ DEMO.ipynb                  # Step-by-step pipeline demo
â”‚   â”œâ”€â”€ ligand_images/              # Molecular visualizations
â”‚   â””â”€â”€ results_output/             # Example outputs
â”‚
â”œâ”€â”€ ğŸ“ Final_Results/                # Curated final compound recommendations
â”‚   â”œâ”€â”€ top_37_ligand_smiles_actives.txt
â”‚   â”œâ”€â”€ top_19_ligand_smiles_inactives.txt
â”‚   â””â”€â”€ top_40935_ligand_scores.txt
â”‚
â”œâ”€â”€ ğŸ“ Some_Helper_Functions/        # Utility scripts
â””â”€â”€ ğŸ“ Some_Results/                 # Intermediate analysis results
```

## ğŸ”§ Installation & Setup

### Prerequisites
- Python 3.8+
- Conda (recommended)
- NVIDIA API access (for MolMIM and DiffDock)
- RDKit

### Environment Setup

```bash
# Clone the repository
git clone https://github.com/Socks2109/drug_discovery_pipeline.git
cd drug_discovery_pipeline

# Create conda environment
conda create -n drug-discovery python=3.10.11
conda activate drug-discovery

# Install RDKit
conda install -c rdkit rdkit

# Install other dependencies
pip install -r requirements.txt
```

### API Configuration

1. **NVIDIA API Key**: Create a `.env` file with your NVIDIA BioNeMo API key:
   ```
   NVIDIA_API_KEY=your_api_key_here
   ```

2. **Authentication**: Update git credentials for collaboration:
   ```bash
   git config --global user.name "YourUsername"
   git config --global user.email "your.email@example.com"
   ```

## ğŸš€ Quick Start

### Option 1: Run the Complete DEMO
```bash
cd DEMO/
jupyter notebook DEMO.ipynb
```

### Option 2: Step-by-Step Execution
```bash
# 1. Generate compound library
cd "01 Library Generation/SEA_MolMIM_SMILELibraryGeneration/"
python LibraryGeneration_MolMIM_BatchProcessing.py

# 2. Convert SMILES to SDF and run docking
cd "../../02 Docking Pipeline/"
python before_diffdock_smiles_to_sdf.py
python diffdock_submit.py

# 3. Evaluate toxicity and PK properties
cd "../03 TxGemma Pipeline/"
jupyter notebook Agentic_TxGemma_Toxicity.ipynb
```

## ğŸ“Š Pipeline Components

### ğŸ§ª Stage 1: Library Generation
- **Input**: Known HIF-2Î± modulators (SMILES)
- **Process**: 
  - SEA analysis for compound diversification
  - MolMIM-based molecular generation
  - Chemical space exploration
- **Output**: Diverse compound libraries

### ğŸ¯ Stage 2: Molecular Docking
- **Input**: Generated compound libraries + HIF-2Î± structure
- **Process**:
  - SMILES to 3D structure conversion (RDKit)
  - DiffDock AI-powered pose prediction
  - Binding affinity scoring
- **Output**: Ranked compounds by binding affinity

### ğŸ” Stage 3: ADMET Filtering
- **Input**: Top-ranked compounds
- **Process**:
  - Toxicity prediction (AMES, ClinTox)
  - PK property evaluation (F, tÂ½, VDss)
  - Lipinski's Rule of Five filtering
- **Output**: Drug-like, non-toxic candidates

### ğŸ“‹ Stage 4: Final Selection
- **Input**: Filtered candidates
- **Process**: Multi-criteria optimization
- **Output**: Final compound recommendations

## ğŸ“ˆ Results

### ğŸ† Key Achievements
- **40,935** compounds initially screened
- **37** high-confidence active compounds identified
- **19** inactive compounds for comparison
- **Average confidence score**: 0.95+ for top candidates

### ğŸ“Š Performance Metrics
- **AMES Mutagenicity AUROC**: 0.798
- **ClinTox AUROC**: 0.831
- **Oral Bioavailability AUROC**: 0.655
- **Half-life Spearman Correlation**: 0.494
- **VDss Spearman Correlation**: 0.607

### ğŸ§¬ Top Compounds
The final recommended compounds show:
- High binding affinity to HIF-2Î±
- Favorable ADMET properties
- Drug-like characteristics
- Low toxicity profiles

*Detailed results available in `Final_Results/` directory*

## ğŸ”¬ DEMO

The `DEMO/` directory contains a complete walkthrough:
- **DEMO.ipynb**: Interactive Jupyter notebook
- **Sample Data**: 36 ligands with full pipeline results
- **Visualizations**: Molecular structures and binding poses
- **Performance Analysis**: Comprehensive metrics and comparisons

## ğŸ“š Detailed Documentation

- [Library Generation Guide](./01%20Library%20Generation/SEA_MolMIM_SMILELibraryGeneration/readme.md)
- [Docking Pipeline Manual](./02%20Docking%20Pipeline/README.md)
- [TxGemma Documentation](./03%20TxGemma%20Pipeline/README.md)
- [AutoDock Documentation](https://github.com/JoeVonDahab/drug_discovery_pipeline/blob/main/02%20Docking%20Pipeline/AutoDOCK%20Pipeline/readme.md)


## ğŸ¤ Contributing

We welcome contributions! Please see our contributing guidelines:

1. Fork the repository
2. Create a feature branch
3. Make your changes
4. Add tests if applicable
5. Submit a pull request

### ğŸ› Issues
Please report bugs and feature requests through [GitHub Issues](https://github.com/Socks2109/drug_discovery_pipeline/issues).

## ğŸ“„ License

This project is licensed under the MIT License - see the [LICENSE](LICENSE) file for details.

## ğŸ™ Acknowledgments

### ğŸ”¬ Scientific References
- **MolMIM**: Nikolaus Hansen. The CMA Evolution Strategy. 2005
- **SEA**: Keiser MJ, et al. Relating protein pharmacology by ligand chemistry. Nat Biotech 25 (2), 197-206 (2007)
- **DiffDock**: NVIDIA BioNeMo Platform

### ğŸ› ï¸ Tools & Libraries
- **RDKit**: Open-source cheminformatics
- **NVIDIA BioNeMo**: AI-powered drug discovery platform
- **Jupyter**: Interactive development environment

### ğŸ‘¥ Team
- **Isaac Yeoh** (TxGemma) â€” [@Socks2109](https://github.com/Socks2109)  
- **Youssef Abo-Dahab** (AutoDock) â€” [@JoeVonDahab](https://github.com/JoeVonDahab)  
- **Shyiang** (DiffDock, Piepline connecting) â€” [@abcdefucsb](https://github.com/abcdefucsb)  
- **Somayeh Motevalli** (TxGemma) â€” [@SomayehMotevalli](https://github.com/SomayehMotevalli)  
- **Miko Mallari** (MolMIM) â€” [@mf-mallari](https://github.com/mf-mallari)

---

**Pipeline Workflow:**

![Pipeline Overview](https://github.com/user-attachments/assets/2dd102ab-23d1-428f-bf5a-87998a5f2f96)

*The pipeline successfully identified 37 high-confidence HIF-2Î± modulators through an integrated AI-driven approach combining generative chemistry, molecular docking, and ADMET prediction.*

---

**ğŸ“§ Contact**: For questions or collaboration opportunities, please open an issue or contact the development team.

**ğŸŒŸ Star this repository** if you find it useful for your drug discovery research!
